Biotechnology company ZandCell LLC reported on Tuesday the availability of a fast, reliable and affordable COVID-19 saliva based rapid antigen test kit to be used in airports, governments, states, hospitals, sports events and for healthcare workers.
According to ZandCell, its COVID-19 Rapid Antigen Test rapidly tests to qualitatively detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high accuracy.
The saliva-based ZandCell COVID-19 Rapid Antigen Test is now available in large quantities and can quickly and effectively test patients for the infectious virus and provide immediate results within three to ten minutes.
ZandCell COVID-19 Rapid Antigen Test was CE certified on 11 September and will be available in the US upon EUA FDA approval.
Redx reports positive Phase 2a data for zelasudil in idiopathic pulmonary fibrosis
Generate:Biomedicines reports results from Phase 1 study of GB-0895
Sichuan Kelun-Biotech Biopharmaceutical NDA for A400 accepted for review in China
Akeso showcasing late-breaking abstract from ivonescimab study at ESMO
TransMedics and Mercedes-Benz to launch dedicated organ transport network in Italy
N4 Pharma advances RNA delivery breakthrough with SRI collaboration
CorestemChemon presents Neuronata-R Phase 3 results at PACTALS 2025
AstraZeneca's Fasenra misses primary endpoint in Phase III COPD trial
GSK commits USD30bn to US R&D and manufacturing expansion
Hydrosome Labs announces promising fermentation breakthrough with ultrafine bubbles